High sensitivity troponin and COVID-19 outcomes
Νικόλαος Παπαγεωργίου, Catrin Sohrabi, David Prieto‐Merino, Angelos Tyrlis, Abed Elfattah Atieh, Bunny Saberwal, Wei-Yao Lim, António Creta, Mohammed Y Khanji, Reni Rusinova, Bashistraj Chooneea, Raj Khiani, Nadeev Wijesuriya, Anna Chow, Haroun Butt, Stefan Browne, Nikhil Joshi, Jamie Kay, Syed Ahsan, Rui Providência
Abstract
BACKGROUND: Recent reports have demonstrated high troponin levels in patients affected with COVID-19. In the present study, we aimed to determine the association between admission and peak troponin levels and COVID-19 outcomes. METHODS: This was an observational multi-ethnic multi-centre study in a UK cohort of 434 patients admitted and diagnosed COVID-19 positive, across six hospitals in London, UK during the second half of March 2020. RESULTS: < .001). CONCLUSIONS: Admission and peak troponin appear to be predictors for cardiovascular and non-cardiovascular events and outcomes in COVID-19 patients, and their utilisation may have an impact on patient management.